Safety concerns about Johnson & Johnson’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting unused. J&J’s …
Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots. Europe’s health regulator, …
The U.S. Food and Drug Administration has asked Emergent BioSolutions Inc. to halt producing new materials for COVID-19 vaccines until the regulator completes an inspection of its plant in Baltimore, which is under scrutiny after millions of doses were thrown …
